| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Harpoon Therapeutics, Inc. | Director | Common Stock | 21K | $484K | $23.00 | Apr 1, 2023 | Direct |
| Finch Therapeutics Group, Inc. | Director | Stock Option (right to buy) | 44.8K | Jun 13, 2022 | Direct | ||
| Graphite Bio, Inc. | Director | Stock Option (right to buy) | 20K | Jul 19, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GRPH | Graphite Bio, Inc. | Jul 19, 2023 | 1 | $0 | 4 | Jul 21, 2023 | Director |
| HARP | Harpoon Therapeutics, Inc. | Apr 1, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Director |
| HARP | Harpoon Therapeutics, Inc. | Jun 22, 2022 | 2 | $52.5K | 4 | Jun 24, 2022 | Director |
| GRPH | Graphite Bio, Inc. | Jun 21, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director |
| FNCH | Finch Therapeutics Group, Inc. | Jun 13, 2022 | 1 | $0 | 4 | Jun 15, 2022 | Director |
| GRPH | Graphite Bio, Inc. | Jun 24, 2021 | 0 | $0 | 3 | Jun 24, 2021 | Director |
| FNCH | Finch Therapeutics Group, Inc. | May 12, 2021 | 1 | $0 | 4 | May 14, 2021 | Director |
| HARP | Harpoon Therapeutics, Inc. | May 4, 2021 | 2 | $0 | 4/A | May 14, 2021 | Director |